Advertisement

Topics

Orthopedic Surgeon, Dr. Mark McFarland, Completes Milestone Case With NanoFUSE® Biologics Technology

23:06 EDT 16 Apr 2019 | Bio-Medicine

MALDEN, Mass. (PRWEB) April 17, 2019 NanoFUSE Biologics announced today that Dr. Mark McFarland completed his 50th case using NanoFUSE Biologics. The operation took place on Thursday, March 28, 2019 at Mary Immaculate Hospital in Newport News, Virginia. Dr. McFarland performed a posterior l...

Original Article: Orthopedic Surgeon, Dr. Mark McFarland, Completes Milestone Case With NanoFUSE® Biologics Technology

NEXT ARTICLE

More From BioPortfolio on "Orthopedic Surgeon, Dr. Mark McFarland, Completes Milestone Case With NanoFUSE® Biologics Technology"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biotherapeutics
The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Biotherapeutics, also known as biotech drugs or biologics, are therapies derived from living organisms. By harnessing these living cells...